NSE Initiates Development of In-House GenAI Tools to Enhance Compliance and Efficiency
NSE developing in-house GenAI tools for compliance, operational efficiency
Business Standard
Image: Business Standard
The National Stock Exchange (NSE) is developing in-house generative artificial intelligence (GenAI) tools focused on compliance and operational efficiency. This initiative comes as the exchange reported a 10% increase in technology costs, reaching ₹1,315 crore for FY26, alongside plans for an upcoming initial public offering (IPO).
- 01NSE is creating GenAI tools for compliance and operational efficiency.
- 02Technology expenses rose to ₹1,315 crore in FY26, a 10% increase from the previous year.
- 03The exchange plans to file IPO draft documents by June 15, 2024.
- 04NSE's consolidated net profit for Q4FY26 was ₹2,871 crore, an 8.3% year-on-year increase.
- 05A dividend of ₹35 per share has been proposed, pending shareholder approval.
Advertisement
In-Article Ad
The National Stock Exchange (NSE) is in the early stages of developing in-house generative artificial intelligence (GenAI) tools aimed at enhancing compliance, customer support, operational efficiency, and software development. This initiative is part of a broader effort to strengthen the exchange's technology infrastructure, which has seen a 10% increase in costs, totaling ₹1,315 crore for the fiscal year 2025-26 (FY26), compared to ₹1,022 crore in FY25. NSE's managing director and CEO, Ashishkumar Chauhan, emphasized that the increase is necessary to build resilience and accommodate growing trading volumes. Additionally, the exchange is preparing for an initial public offering (IPO), targeting June 15, 2024, for filing draft documents, with existing shareholders expected to dilute up to 5% of their stakes. NSE reported a consolidated net profit of ₹2,871 crore for Q4FY26, marking an 8.3% year-on-year increase, and its revenue from operations surged to ₹4,967.59 crore, up from ₹3,771.41 crore a year earlier. The board has also recommended a dividend of ₹35 per share, subject to shareholder approval.
Advertisement
In-Article Ad
The development of GenAI tools may streamline operations and improve compliance, potentially leading to better services for investors and traders.
Advertisement
In-Article Ad
Reader Poll
Do you believe the development of GenAI tools will enhance NSE's operational efficiency?
Connecting to poll...
More about National Stock Exchange
Read the original article
Visit the source for the complete story.
